Q32 Bio Inc.
SEC CIK 1661998 · QTTB · last insider filing 2026-06-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Laporte Kathleen | Director | filed 2024–2026 |
| Thistle Mary | Director | filed 2018–2026 |
| Iwicki Mark T | Director | filed 2024–2026 |
| Tzianabos Arthur | Director · President & CEO | filed 2018–2026 |
| Manke Isaac | Director | filed 2024–2026 |
| Lundberg Sven Ante | Director | filed 2024–2026 |
| Grayzel David S. | Director | filed 2024–2026 |
| Xu Diyong | Director | filed 2024–2026 |
| Orbimed Advisors LLC | Director | filed 2024–2026 |
| Orbimed Capital GP VII LLC | Director | filed 2024–2026 |
| Orbimed Genesis GP LLC | Director | filed 2026–2026 |
| Morrison Jodie Pope | Director · CEO | filed 2024–2026 |
| Seymour Albert | Director · See remarks | filed 2018–2023 |
| Gillis Steven | Director | filed 2018–2023 |
| Patterson Matthew R | Director | filed 2018–2023 |
| Reicin Alise | Director | filed 2019–2023 |
| Poulton Jeffrey V. | Director | filed 2020–2023 |
| Gregory Richard J. | Director | filed 2018–2022 |
| Parmar Kush | Director | filed 2018–2022 |
| Deerfield Management Company, L.P. (Series C) | Director | filed 2018–2020 |
| Deerfield Mgmt L.P. | Director | filed 2018–2020 |
| Deerfield Partners, LP | Director | filed 2018–2020 |
| Flynn James E | Director | filed 2018–2020 |
| Deerfield Private Design Fund III, L.P. | Director | filed 2018–2020 |
| Deerfield Mgmt III, L.P. | Director | filed 2018–2020 |
| Deerfield Healthcare Innovations Fund, L.P. | Director | filed 2018–2020 |
| Deerfield Mgmt HIF, L.P. | Director | filed 2018–2020 |
| Wheeler Cameron | Director | filed 2018–2019 |
| Shah Mahendra | Director | filed 2018–2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kalowski Lee | CFO and President | filed 2024–2026 |
| Violette Shelia M. | Chief Scientific Officer | filed 2024–2026 |
| Campagna Jason | Chief Medical Officer | filed 2024–2025 |
| Alloway Paul | See Remarks | filed 2022–2024 |
| Michaud Charles Jr | See Remarks | filed 2023–2024 |
| Jordan Julie | Chief Medical Officer | filed 2023–2023 |
| Smith W Bradford | See remarks | filed 2018–2023 |
| Blum Michael Lee | Chief Commercial Officer | filed 2022–2023 |
| Kelly Timothy P | See Remarks. | filed 2018–2022 |
| Cohn Gabriel | Chief Medical Officer | filed 2019–2022 |
| Rasty Siyamak | Chief Operating Officer | filed 2018–2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.